then 2-cyanoethyl-N, N-diisopropylchlorophosphoramidite (2.15 mL) was added dropwise. The reaction mixture was stirred at room temperature for 1 h and then at 80 °C for 1.5 h. The solution was then cooled to room temperature, washed with 5% NaHCO 3 and brine, Na 2 SO 4 dried, and vacuum concentrated. The product was precipitated as a white solid by adding the concentrated solution to 5 CH 3 CN. The product was identified by 1 H NMR and 31 P NMR according to data reported in the literature. [1] Scheme S1. Detailed synthesis route for lipid phosphoramidite.
(2) Synthesis of oligonucleotide probes
All oligonucleotide probes were synthesized on an automated ABI 3400 DNA synthesizer 10 (Applied Biosystems, Foster City, CA, USA) by solid phase oligonucleotide synthesis starting from the corresponding controlled pore glass (CPG) beads. Lipid phosphoramidite was dissolved in CH 2 Cl 2 and then coupled onto the oligonucleotide sequences. Oligonucleotide probes containing carboxytetramethylrhodamine (TAMRA) were deprotected in 3 mL TAMRA deprotection solution (methanol : tert-butylamine : water = 1: 1 : 2) at 65 °C for 4 h, and all others were deprotected in 3 mL 15 AMA solution (ammonium hydroxide : 40% aqueous methylamine = 1 : 1) at 65 °C for 30 min. All oligonucleotide probes were precipitated by adding 250 μL of 3 M NaCl and 6 mL of cold CH 3 CH 2 OH.
Then the precipitated oligonucleotide probes were collected by centrifugation at 4000 rpm for 30 min and dissolved in 400 μL of triethylammonium acetate (TEAA) for further purification by reversedphase high-pressure liquid chromatography (HPLC) (ProStar, Varian, Walnut Creek, CA, USA).
Oligonucleotide probes with and without diacyllipid were purified using C4 and C18 columns, 5 respectively, using CH 3 CN-TEAA solution as the mobile phase. Finally, these oligonucleotide probes were quantified by measuring their absorbances at 260 nm using a Varian Cary 100 UV-Vis spectrometer (Agilent Technologies, Santa Clara, CA, USA). The DNA sequences are shown in Table   S1 . Table S1 : Detailed sequence information for all oligonucleotide probes Name Sequence
The red regions in the above table correspond to Sgc8 aptamer. Underline denotes base pairs of DOX loading sites.
(3) Synthesis of nanoparticles
The nanoparticles were synthesized as previously described [2] using Lipid-PEG-DNA triblock 15 ligands. A 3-mL DSPE-PEG/Lipid-PEG-DNA/lecithin mixture in 4% ethanol containing 0.17 mg DSPE-PEG /Lipid-PEG-DNA (1:4 molar ratio) and 0.08 mg lecithin was heated for 3 min above the lipid phase transition temperature (68 °C) with gentle stirring. After heating, 1 mg of PLGA with 0.1 mg PTX in 1 mL acetone was added dropwise at 1 mL/min. The solution was vortexed vigorously for 3 min, followed by self-assembly under gentle stirring for 2 h at RT. The NPs were washed three times using an Amicon Ultra-4 centrifugal filter with 100,000 Da molecular weight cutoff (Millipore). The
NPs were resuspended in pH 7.2 PBS buffer and 2 mM EDTA and incubated with 1 µM DOX for 30 min at RT. The NPs were again washed three times using an Amicon Ultra-4 centrifugal filter with 5 30,000 Da molecular weight cutoff (Millipore) to remove the free doxorubicin.
(4) Characterization of Nanoparticles TEM grids were prepared by adding NP samples (1 mg/mL) in H 2 O onto copper grids. Samples were blotted after 10 min, and the grids were negatively stained for 10 min at RT with freshly prepared, sterile-filtered, 3 wt% uranyl acetate solution. The uranyl acetate solution was blotted away, and the 10 grids were air dried before imaging. DLS measurements were performed on a ZetaPALS DLS detector (Brookhaven Instruments, Holtsville, NY, USA) at 25 °C, using a 3 mL disposable cuvette. The scattering angle was fixed at 90°. The steady-state fluorescence measurements were recorded on a Fluorolog-Tau-3 spectrofluorometer (Jobin Yvon, Edison, NJ) with a 0.2 cm quartz cell, using a bandpass of 5 nm for both excitation and emission. To ensure that the PTX had been encapsulated into the 15 nanoparticles, 0.1 mL of the nanoparticle solution (1mg/mL) was mixed with an equal volume of acetonitrile to dissolve the NPs. PTX content was quantified by HPLC (ProStar, Varian, Walnut Creek, CA, USA) at a retention time of ~12-16 min in a 1 mL/min, 1/1 acetonitrile/water, isochratic mobile phase. PTX absorbance was measured at 227 nm using a UV-Vis detector. Finally, the amount of PTX retained was calculated on the basis of the peak area. References:
